Complement Modulation of Anti-Aging Factor Klotho in Ischemia/Reperfusion Injury and Delayed Graft Function

Area of Science:

• Nephrology
• Immunology
• Aging Research

Background:

• Klotho is a key anti-aging protein primarily produced by kidney tubular epithelial cells (TEC).
• Klotho levels decrease in acute kidney injury, but its role in kidney transplantation is unknown.
• Reduced Klotho is linked to senescence and fibrosis, processes relevant to chronic allograft dysfunction.

Purpose of the Study:

• Investigate Klotho modulation in kidney transplantation following ischemia/reperfusion injury (IRI).
• Determine the role of complement activation in Klotho down-regulation post-transplant.
• Assess the association between Klotho levels and delayed graft function (DGF) and long-term outcomes.

Main Methods:

• Utilized a swine model of kidney IRI to assess Klotho expression.
• Investigated complement inhibition (C1-inhibitor) effects on Klotho and NF-kB signaling.
• Examined Klotho expression in human kidney biopsies and serum levels in transplant recipients.

Main Results:

• IRI significantly reduced renal Klotho expression within 24 hours.
• Complement inhibition preserved Klotho by inhibiting NF-kB signaling.
• TEC exposed to C5a showed NF-kB-mediated Klotho down-regulation in vitro.
• Kidney transplant recipients with DGF exhibited lower Klotho expression in biopsies and serum compared to those with early graft function.

Conclusions:

• Complement activation plays a critical role in the down-regulation of Klotho during kidney IRI.
• Acquired Klotho deficiency post-transplantation may persist long-term.
• This Klotho deficiency is hypothesized to contribute to DGF-associated chronic allograft dysfunction.